Perfil
Kolby Day is currently the Chief Operating Officer at Biomebank since 2023.
Prior to this, he worked as a Principal at Myriad Genetics, Inc. and as the VP, General Manager-Research & Development at Arteriocyte Medical Systems, Inc. Mr. Day has a graduate degree from Case Western Reserve University and an undergraduate degree from Southern Utah University.
Cargos activos de Kolby Day
| Empresas | Cargo | Inicio |
|---|---|---|
Biomebank
Biomebank BiotechnologyHealth Technology Provides research and development in drugs and micro biome based therapies | Director de Operaciones | 29/08/2023 |
Antiguos cargos conocidos de Kolby Day.
| Empresas | Cargo | Fin |
|---|---|---|
| MYRIAD GENETICS, INC. | Corporate Officer/Principal | - |
Arteriocyte Medical Systems, Inc.
Arteriocyte Medical Systems, Inc. Medical SpecialtiesHealth Technology Develops and markets novel medical products | Director Técnico/Científico/I+D | - |
Formación de Kolby Day.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Myriad Genetics, Inc.
Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Arteriocyte Medical Systems, Inc.
Arteriocyte Medical Systems, Inc. Medical SpecialtiesHealth Technology Develops and markets novel medical products | Health Technology |
Case Western Reserve University
Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Southern Utah University
Southern Utah University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biomebank
Biomebank BiotechnologyHealth Technology Provides research and development in drugs and micro biome based therapies | Health Technology |
- Bolsa de valores
- Insiders
- Kolby Day
















